Antipruritic agent

"Antipruritic agent" is a broad pharmacological classification for drugs and substances intended to prevent or relieve pruritus, or itching (StatPearls, 2023). This term does not refer to a single molecular target but rather encompasses a variety of agents that interact with different biological pathways, such as the histaminergic, opioid, and cytokine signaling systems (NIH, 2022). Common molecular targets for these agents include the Histamine H1 receptor, Kappa-opioid receptors, and the Interleukin-31 receptor A (IL-31RA) (PubMed, 2021). These agents are critical in managing the symptoms of diverse conditions ranging from simple insect bites and allergic reactions to complex systemic diseases like chronic kidney disease and cholestasis (Mayo Clinic, 2023). By targeting the specific neuro-immune interfaces responsible for itch transmission, antipruritic agents help break the debilitating 'itch-scratch cycle' and improve patient quality of life.

Other names

Anti-itch agentAntipruriticItch-relieving medicationPruritus treatment

Antipruritic agents work through diverse mechanisms depending on the etiology of the itch, including Histamine H1 receptor antagonism, Kappa-opioid receptor (KOR) agonism, Mu-opioid receptor (MOR) antagonism, inhibition of the Interleukin-31 (IL-31) pathway, and modulation of transient receptor potential (TRP) channels.